Journal Articles
Disclaimer: The papers below are intended for private viewing by the page owner or those who otherwise have legitimate access to them. No part of it may in any form or by any electronic, mechanical, photocopying, recording, or any other means be reproduced, stored in a retrieval system or be broadcast or transmitted without the prior permission of the respective publishers. If your organization has a valid subscription of the journals, click on the DOI link for the legitimate copy of the papers.
View By Year Published
2016-2017
Pergolizzi JV Jr, LeQuang JA Ba, Taylor R Jr, Raffa RB; NEMA Research Group
The “Darknet”: The new street for street drugs J Clin Pharm Ther. 2017 Dec;42(6):790-792
Tabor A, Pergolizzi JV Jr, Marti G, Harmon J, Cohen B, Lequang JA
Raising Awareness Among Healthcare Providers about Epidermolysis Bullosa and Advancing Toward a Cure J Clin Aesthet Dermatol. 2017 May;10(5):36-48
Pergolizzi JV, Curro FA, Col N, Ghods MP, Vena D, Taylor R, Naftolin F, LeQuang JA
A multicentre evaluation of an opioid patient-provider agreement. Postgrad Med J. 2017 Oct;93(1104):613-617
DOI:10.1136/postgradmedj-2016-134607
Nassar MS, Hasan A, Chila T, Schueler S, Pergolizzi C, Reinhardt Z, Lord S, De Rita F, Ferguson L, Smith J, Haynes S, O'Sullivan J, Murtuza B.
Comparison of paracorporeal and continuous flow ventricular assist devices in children: preliminary results Eur J Cardiothorac Surg. 2017 Apr 1;51(4):709-714
Müller-Schwefe G, Morlion B, Ahlbeck K, Alon E, Coaccioli S, Coluzzi F, Huygen F, Jaksch W, Kalso E, Kocot-Kępska M, Kress HG, Mangas AC, Margarit Ferri C, Mavrocordatos P, Nicolaou A, Hernández CP, Pergolizzi J, Schäfer M, Sichère P.
Treatment for chronic low back pain: the focus should change to multimodal management that reflects the underlying pain mechanisms Curr Med Res Opin. 2017 Jul;33(7):1199-1210
DOI:10.1080/03007995.2017.1298521
Lin TC, Ger LP, Pergolizzi JV Jr, Raffa RB, Wang JO, Ho ST
Long-term use of opioids in 210 officially registered patients with chronic noncancer pain in Taiwan: A cross-sectional study J Formos Med Assoc. 2017 Apr;116(4):257-265
DOI:10.1016/j.jfma.2016.10.015
Pasqualucci A., Nadhari MY., Vaidyan KPT., Varrassi G., LeQuang J., Pergolizzi JV., and Paladini A
Role Of Anesthetist In Sedation For Diagnostic Procedures: The Glass Is Half Empty? A Narrative Review SOJ Anesthesiol Pain Manag. 2017 4(2): 1-4
Fleischer BC, Pergolizzi JV, Papagallo M, Taylor R and LeQuang JA
Trigeminal Trophic Syndrome: A Case Report Austin J Anesthesia and Analgesia - Volume 5 Issue 2 - 2017
Pergolizzi. J., Taylor R., LeQuang J., Bisney J., Breve F., Annabi M., Annabi H., and Colucci S.
The Evolution of Abuse-Deterrent Extended-Release Opioid Formulations: Is there a Place in the Armamentarium for More Products? EC Anaesthesia 3.2 (2017): 64-77
Pergolizzi JV, Raffa RB, Taylor R, et al.
Opioid Therapy for Chronic Noncancer Pain: Safe, Effective, Appropriate? Kaye AD, ed. Scientific American Pain Management [online]. Hamilton: Decker; January 2017
Pergolizzi JV Jr, Taylor R, LeQuang JA, Zampogna G, Raffa RB
Concise review of the management of iatrogenic emesis using cannabinoids: emphasis on nabilone for chemotherapy-induced nausea and vomiting. Cancer Chemother Pharmacol 2017 Mar;79(3):467-477
Broglio K, Pergolizzi J, Kowalski M, Lunch SY, HeE, Wen W.
Efficacy and safety of once-daily extended-release (ER) hydrocodone in individuals previously receiving ER morphine for chronic pain Pain Pract. 2017 Mar; 17(3):382-391
Broglio K, Pergolizzi J, Kowalski M, Lunch SY, HeE, Wen W
Long-term effectiveness of once-daily, single-entity, extended-release hydrocodone in patients of ≥ 75 years of age with moderate to severe nonmalignant and nonneuropathic pain Geriatr Nurs. 2017 Jan-Feb; 38(1):39-47
Raffa RB, Taylor R Jr. Pergolizzi JV Jr, Nalamachu S, Edwards ES, Edwards ET
Application of human factors engineering (HFE) to the design of a naloxone auto-injector for the treatment of opioid emergencies Drug Deliver Transl Res. 2017 Feb; 7(1):1-10
Pergolizzi JV, Raffa RB, Marcum Z, Colucci S, Ripa SR
Safety of buprenorphine transdermal system in the management of pain in older adults Postgrad Med. 2017 Jan; 129(1):92-101
Pergolizzi JV Jr, Raffa RB, Pappagallo M, Fleischer C, Pergolizzi J 3rd, Zampogna G, Duval E, Hismeh J, LeQuang JA, Taylor R Jr
Peripherally acting µ-opioid receptor antagonists as treatment options for constipation in noncancer pain patients on chronic opioid therapy Patient Pref Adherence 2017 Jan 17; 11:107-0119
Pergolizzi JV Jr, Taylor R, LeQuang JA, Zampogna G, Raffa RB.
Concise review of the management of iatrogenic emesis using cannabinoids: emphasis on nabilone for chemotherapy-induced nausea and vomiting Cancer Chemother Pharmacol 2017 Mar; 79(3):467-477.
Müller-Schwefe G, Morlion B, Ahlbeck K, Alon E, Coaccioli S, Coluzzi F, Huygen F, Jaksch W, Kalso E, Kocot-Kępska M, Kress HG, Mangas AC, Margarit Ferri C, Mavrocordatos P, Nicolaou A, Hernández CP, Pergolizzi J, Schaefer M, Sichère P.
Treatment for chronic low back pain: the focus should change to multimodal management that reflects the underlying pain mechanisms Curr Med Res Opin 2017 Feb 22
DOI:10.1080/03007995.2017.1298521
Lin TC, Ger LP, Pergolizzi JV Jr. Raffa RB, Wang JO, Ho ST
Long-term use of opioids in 210 officially registered patients with chronic noncancer pain in Taiwan: A cross-sectional study J Formos Med Assoc. 2016 Dec 23
Pergolizzi, J.V., et al
Pain Specialists Awareness of Topical Analgesics and Their Use in Pain Control: Survey Results. (2016) J Anesth Surg 3(3): 1- 5
Pergolizzi JV, Zampogna G, Robert Taylor Jr, Raffa RB
(2016) Insights into Chronic Postsurgical Pain. Int J Surg Res. 3(5), 55-60
Pergolizzi J, Raffa RB, LeQuang JA.
The Centers for Disease Control and Prevention opioid guidelines: potential for unintended consequences and will they be abused? J Clin Pharm Ther. 2016 Dec; 41(6):592-593
Pergolizzi J, Paladini A, Varrassi G, Raffa RB
Change Pain: Ever Evolving-An Update for 2016 Pain Ther. 2016 Oct 14
Pergolizzi JV Jr, Seow-Choen F, Wexner SD, Zampogna G, Raffa RB, Taylor R Jr.
Perspectives on Intravenous Oxycodone for Control of Postoperative Pain Pain Pract. 2016 Sep;16(7):924-34
Pergolizzi J, Raffa RB, Zampogna G, Breve F, Colucci R, Schmidt WK, LeQuang JA.
Comments and Suggestions from Pain Specialists Regarding the CDC’s Proposed Opioid Guidelines Pain Pract. 2016 Sep;16(7):794-808
Lin TC, Ger LP, Pergolizzi J, Raffa RB, Wang JO, Ho ST.
Knowledge, Attitude and Practice Survey of Prescribing Opioids for Chronic Noncancer Pain in Taiwan-Comparison of Pain and Non-Pain Physicians Pain Med. 2016 Aug 22. pii: pnw189
Raffa RB, Taylor R Jr, Pergolizzi JV Jr, Nalamachu S, Edwards ES, Edwards ET
Application of human factors engineering (HFE) to the design of a naloxone auto-injector for the treatment of opioid emergencies Drug Deliv Transl Res. 2016 Aug 25
Coluzzi F, Taylor R Jr, Pergolizzi J, Mattia C, Raffa RB
Good clinical practice guide for opioids in pain management: the three Ts – titration (trial), tweaking (tailoring), transition (tapering) Rev Bras Anestesiol. 2016 May-Jun; 66 (3):310-7
DOI:10.1016/j.bjan.2016.02.008
Coluzzi F, Taylor R Jr, Pergolizzi J Mattia C, Raffa RB, Braz J
Good clinical practice guide for opioids in pain management: the three Ts – titration (trial), tweaking (tailoring), transition (tapering). Anesthesiol. 2016 May-Jun; 66 (3):310-7.
DOI:10.1016/j.bjane.2014.09.005
Pergolizzi J, Raffa RB, Nalamachu S, Taylor R Jr
Evolution to low-dose NSAID therapy. Pain Manag. 2016 Apr;6(2):175-89
Pergolizzi J, Zampogna G, Taylor R, Gonima E, Posada J, Raffa RB
A Guide for Pain Management in Low and Middle Income Communities. Managing the Risk of Opioid Abuse in Patients with Cancer Pain Front Pharmacol. 2016 Mar 1;7:42
Yarlas A, Miller K, Wen W, Lynch SY, Munera C, Dain B, Pergolizzi J, Raffa R, Ripa SR.
Buprenorphine Transdermal System Improves Sleep Quality and Reduces Sleep Disturbance in Patients with Moderate-to-Severe Chronic Low Back Pain: Results from Two Randomized Controlled Trials Pain Pract. 2016 Mar;16(3):345-58